ArticleClinical neuropsychiatry2026
Glycemic Control, Quality Of Life, And Social Determinants Of Sleep Quality In Newly Diagnosed Type 2 Diabetes Mellitus.
Article in Clinical neuropsychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the prevalence of poor sleep quality and identify associated factors among patients newly diagnosed with T2DM. Method: A cross-sectional study was conducted at the National Hospital of Endocrinology, Vietnam, from August 2024 to July 2025. A total of 106 patients with newly diagnosed T2DM were recruited. Data on sociodemographics, lifestyle, clinical and biochemical measures, social support (MSPSS), and quality of life (WHOQOL-BREF) were collected. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Logistic regression was applied to identify predictors of sleep disorder (PSQI ≥5), and Tobit regression was used to examine determinants of the total PSQI score. Results: The mean PSQI global score was 6.86 ± 4.63, and 67.9% of participants experienced at least mild sleep disturbance. Logistic regression showed that elevated HbA1c (OR = 7.66, 95% CI: 2.81-20.86, p < 0.001) and female sex (OR = 0.13, 95% CI: 0.02-0.82, p = 0.029) were significant predictors of poor sleep. Tobit regression further identified HbA1c (Coef. = 1.45, p < 0.001), female sex (Coef. = -3.40, p < 0.001), economic stress (Coef. = -3.42, p < 0.001), WHOQOL physical (Coef. = -0.07, p = 0.027), and WHOQOL environment (Coef. = 0.11, p = 0.012) as significant determinants of PSQI score. Lifestyle factors and family support showed weaker or non-significant associations. Conclusions: These findings suggest that sleep should be routinely assessed at diagnosis, with integrated management strategies addressing biomedical, psychosocial, and environmental determinants to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.